TrialAmerican journal of clinical oncology2019

Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.

Chi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.